Global Pemirolast Market – Dynamics
Rising incidence of allergic conjunctivitis is expected to propel growth of the global pemirolast market over the forecast period. For instance, according to the article published in the Asia Pacific Association of Allergy, Asthma and Clinical Immunology, in April 2019, simple allergic conjunctivitis affects around 10% to 30% of the population globally.
Moreover, adoption of inorganic growth strategies such as mergers, collaborations, and acquisitions by major players are expected to propel the market growth over the forecast period. For instance, in March 2017, Nipro Corporation, acquired the Tanabe Seiyaku Hanbai Co., Ltd., an alegysal (potassium pemirolast) manufacturing subsidiary of Mitsubishi Tanabe Pharma Corporation. The acquisition is expected to enhance Nipro’s offerings in the global generic drugs market, including alegysal.
Pemirolast Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients